Haiyan Jiang

This inventor holds 30 USPTO granted patents and 24 published patent applications, plus 6 CIPO patents and 16 EPO patents. Top assignees: Bioverativ Therapeutics Inc., Puget Sound Blood Center, Bayer Healthcare LLC. Active years: 2015-2025.

USPTO Granted Patents = 30 (Patent Applications = 24)

% Patents Active = 96.7

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 16 (Patent Applications = 21)

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 184(Granted Patents)

Location History:

San Francisco, CA (US) (2016 - 2018)
Belmont, MI (US) (2020)
Belmont, MA (US) (2015 - 2023)

Company Filing History:

25 out of 76

Bioverativ Therapeutics Inc.

patents

3 out of 8

Puget Sound Blood Center

Biogen Hemophila Inc.

patent

5. 1 out of 2

Biogen Hemophilia Inc.

patents

6. 1 out of 5

Biogen Idec Hemophilia Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Factor VIII

Immunogenicity Reduction

Chimeric Polypeptides

Bleeding Disorders

Factor IX

Clotting Factors

Population Pharmacokinetics

Targeted Coagulation

Factor VIII Compositions

Hybrid Polypeptides

Assays Development

Therapeutic Applications

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371747 - Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy (2025-07-29),

2. 12186375 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2025-01-07),

3. 11747351 - Assays to monitor bleeding disorders (2023-09-05),

4. 11370827 - Chimeric factor VIII polypeptides and uses thereof (2022-06-28),

5. 11286528 - Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy (2022-03-29),

6. 11266720 - Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof (2022-03-08),

7. 11225650 - Methods of using FIX polypeptides (2022-01-18),

8. 11091534 - Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof (2021-08-17),

9. 10898554 - Factor IX polypeptides and methods of use thereof (2021-01-26),

10. 10881742 - Factor VIII chimeric and hybrid polypeptides, and methods of use thereof (2021-01-05),

11. 10656167 - Assays to monitor bleeding disorders (2020-05-19),

12. 10568943 - Factor IX polypeptides and methods of use thereof (2020-02-25),

13. 10561714 - Factor IX polypeptides and methods of use thereof (2020-02-18),

14. 10548954 - Factor IX polypeptides and methods of use thereof (2020-02-04),

15. 10548953 - Factor VIII-XTEN fusions and uses thereof (2020-02-04),

Title: Inventor Haiyan Jiang: Pioneering Innovations in Belmont

Introduction: Haiyan Jiang is a distinguished inventor based in Belmont, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Jiang holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in innovation.

Career Highlights: With over two decades of experience in research and development, Jiang has worked for leading tech companies, where he spearheaded projects that have resulted in significant advancements in the industry.

Collaborations: Throughout his career, Jiang has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects.

Conclusion: Haiyan Jiang's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true trailblazer in the world of inventors.